We can't find the internet
Attempting to reconnect
25384.1 PFLS-LS
25384.1 PFLS-LS
Zusammenfassung
Identification of the most suitable drug candidate(s) of first selective endocannabinoid reuptake inhibitors (SERIs) for clinical development in neuropsychiatric disorders
Weitere Texte
Abstract
Selective endocannabinoid reuptake inhibitors (SERIs) are new chemical entities that modulate the endocannabinoid system with a potentially more effective and safer pharmacological profile as compared to other cannabinoid drugs. Preliminary analytical and behavioral pharmacology experiments indicate that SERIs are active in the central nervous system. The aim of this project relates to the identification of the best drug candidate(s) for clinical development and selection of the most suitable target indication(s) among neuropsychiatric disorders.
Beteiligte
Andrea Chicca
Kontaktperson
chicca@ibmm.unibe.ch
Universität Bern Institute of Biochemistry and Molec Andrea Chicca Bühlstrasse 28 3012 Bern BE CH
Projektdetails
- Forschungsstelle
- INNOSUISSE
- Projektstatus
- Abgeschlossen
- Projekttyp
- Forschungsprojekt
- Startdatum
- 2017-03-31
- Enddatum
- 2019-05-31
- Bewilligte Gesamtkosten
- CHF 228997.00
- Sektion
- 20 Förderbereich Life Sciences
- NABS Politikbereich
- Industrielle Produktivität und Technologie
Forschungsdisziplinen
- T115 Medical technology 100.0%